title: A Mediation Model to Explain HIV Antiretroviral Adherence Among Gay and Bisexual Men.
abstract: Based on quantitative data describing a sample of 300 HIV seropositive gay and bisexual men living in New York City who were on antiretroviral drug therapy, variables of interest were collapsed into 4 latent constructs-SES (including health care provision), psychological states, drug use impairment, and HIV treatment adherence-and structural equation modeling was used to test the relations among them. Our model indicated a complex interplay between socioeconomic factors, drug use impairment, psychological states, and adherence. It is imperative for counselors and clinicians working with this population to understand the complex relationships between cultural, social, and psychological realities and adherence to HIV antiviral medications and to develop effective socially relevant and culturally nested interventions.
authors.affiliation: Director of Research, Professor of Applied Psychology, and Director of the Center for Health, Identity, Behavior & Prevention Studies (CHIBPS) at The Steinhardt School, New York University.
authors.forename: Perry N
authors.initials: PN
authors.lastname: Halkitis
authors.affiliation: graduate student in Public Health and a research affiliate of CHIBPS at The Steinhardt School.
authors.forename: Joseph
authors.initials: J
authors.lastname: Palamar
keywords: Adherence; HIV; SEM; gay; latent class analysis; treatment
references.citation: Arch Gen Psychiatry. 1961 Jun;4:561-71
references.pmid: 13688369
references.citation: N Engl J Med. 1973 Aug 2;289(5):249-52
references.pmid: 4713764
references.citation: Soc Sci Med. 1991;32(10):1161-7
references.pmid: 2068599
references.citation: JAMA. 1998 Jun 24;279(24):1977-83
references.pmid: 9643862
references.citation: J Nerv Ment Dis. 1993 Jul;181(7):409-16
references.pmid: 8320542
references.citation: J Acquir Immune Defic Syndr. 2000 Apr 1;23(4):360-1
references.pmid: 10836763
references.citation: Science. 1998 May 8;280(5365):867-73
references.pmid: 9572724
references.citation: J Acquir Immune Defic Syndr. 2001 Jan 1;26(1):82-92
references.pmid: 11176272
references.citation: Ann Pharmacother. 1993 Jul-Aug;27(7-8):851-5
references.pmid: 8364262
references.citation: J Natl Med Assoc. 1999 Aug;91(8):439-46
references.pmid: 12656432
references.citation: J Clin Exp Neuropsychol. 1996 Feb;18(1):122-35
references.pmid: 8926291
references.citation: Eur J Epidemiol. 2004;19(6):585-7
references.pmid: 15330132
references.citation: J Clin Oncol. 1993 Jun;11(6):1189-97
references.pmid: 8501505
references.citation: AIDS Patient Care STDS. 2000 Jun;14(6):309-16
references.pmid: 10897503
references.citation: J Urban Health. 2000 Jun;77(2):150-65
references.pmid: 10855997
references.citation: J Urban Health. 2003 Mar;80(1):161-6
references.pmid: 12612105
references.citation: J Int Neuropsychol Soc. 1998 Jul;4(4):319-28
references.pmid: 9656605
references.citation: Nature. 1995 Jan 12;373(6510):123-6
references.pmid: 7816094
references.citation: MMWR Morb Mortal Wkly Rep. 2003 Nov 28;52(47):1145-8
references.pmid: 14647015
references.citation: Nurse Pract. 1993 Dec;18(12):8, 11
references.pmid: 8108049
references.citation: J Health Psychol. 2005 Jul;10(4):545-58
references.pmid: 16014391
references.citation: J Clin Epidemiol. 2004 Oct;57(10):1107-10
references.pmid: 15528063
references.citation: AIDS. 2002 Mar 29;16(5):767-74
references.pmid: 11964533
references.citation: AIDS. 1998 Jul 30;12(11):1398-9
references.pmid: 9708426
references.citation: Curr Infect Dis Rep. 2004 Oct;6(5):404-410
references.pmid: 15461893
references.citation: Int J Clin Pharmacol Ther. 1994 Sep;32(9):452-7
references.pmid: 7820327
references.citation: Ann Intern Med. 2001 May 15;134(10):968-77
references.pmid: 11352698
references.citation: Soc Sci Med. 1994 Oct;39(7):931-48
references.pmid: 7992126
references.citation: Focus. 1998 Feb;13(3):1-4
references.pmid: 11365167
references.citation: J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1;10(2):139-49
references.pmid: 7552477
references.citation: J Acquir Immune Defic Syndr. 2004 Oct 1;37 Suppl 2:S78-87
references.pmid: 15385903
references.citation: AIDS Patient Care STDS. 2003 Apr;17(4):169-77
references.pmid: 12737640
references.citation: AIDS Educ Prev. 1996 Feb;8(1):58-71
references.pmid: 8703641
references.citation: AIDS Care. 2003 Feb;15(1):89-102
references.pmid: 12655837
references.citation: J Gen Intern Med. 2001 Dec;16(12):850-9
references.pmid: 11903765
references.citation: Ann Intern Med. 2000 Jul 4;133(1):21-30
references.pmid: 10877736
references.citation: J Acquir Immune Defic Syndr. 2001 Dec 15;28(5):445-9
references.pmid: 11744832
references.citation: J Pers. 1991 Dec;59(4):733-45
references.pmid: 1774617
references.citation: AIDS Patient Care STDS. 2004 Jul;18(7):385-93
references.pmid: 15307927
references.citation: AIDS. 2000 Mar 10;14(4):357-66
references.pmid: 10770537
references.citation: AIDS Care. 1996 Jun;8(3):261-9
references.pmid: 8827119
references.citation: AIDS. 1998 Dec 3;12(17):2295-303
references.pmid: 9863872
references.citation: Med Care. 1999 Dec;37(12):1270-81
references.pmid: 10599608
references.citation: AIDS. 1997 Nov 15;11(14):1665-70
references.pmid: 9386800